| Dr Christopher L Marsh, DO | |
|
2001 W Orange Grove Rd Ste 612, Tucson, AZ 85704-1141 | |
| (520) 535-2004 | |
| (520) 535-2022 |
| Full Name | Dr Christopher L Marsh |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 2001 W Orange Grove Rd Ste 612, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053412478 | NPI | - | NPPES |
| 144710 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2532 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Choice Medical Group | 6901293547 | 2 |
News Archive
Particle Sciences and Microfluidics extended their collaboration with the placement of the newly-announced Microfluidics Reaction Technology system at Particle Sciences.
Perrigo Company today announced results for its first quarter ended September 26, 2009.
The first study to examine the actual willingness of older adults to be screened for dementia has found that acceptance of screening is pervasive, although it varies by age. However, willingness to be screened for dementia does not differ by sex, race or income level.
Mylan N.V. today announced the U.S. launch of Fluvastatin Sodium Extended-release Tablets, 80 mg, which is the generic version of Novartis' Lescol XL Tablets.
› Verified 8 days ago
| Entity Name | Mdvip365 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639638257 PECOS PAC ID: 0143632125 Enrollment ID: O20201216000489 |
News Archive
Particle Sciences and Microfluidics extended their collaboration with the placement of the newly-announced Microfluidics Reaction Technology system at Particle Sciences.
Perrigo Company today announced results for its first quarter ended September 26, 2009.
The first study to examine the actual willingness of older adults to be screened for dementia has found that acceptance of screening is pervasive, although it varies by age. However, willingness to be screened for dementia does not differ by sex, race or income level.
Mylan N.V. today announced the U.S. launch of Fluvastatin Sodium Extended-release Tablets, 80 mg, which is the generic version of Novartis' Lescol XL Tablets.
› Verified 8 days ago
| Entity Name | Choice Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962142141 PECOS PAC ID: 6901293547 Enrollment ID: O20220428001217 |
News Archive
Particle Sciences and Microfluidics extended their collaboration with the placement of the newly-announced Microfluidics Reaction Technology system at Particle Sciences.
Perrigo Company today announced results for its first quarter ended September 26, 2009.
The first study to examine the actual willingness of older adults to be screened for dementia has found that acceptance of screening is pervasive, although it varies by age. However, willingness to be screened for dementia does not differ by sex, race or income level.
Mylan N.V. today announced the U.S. launch of Fluvastatin Sodium Extended-release Tablets, 80 mg, which is the generic version of Novartis' Lescol XL Tablets.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher L Marsh, DO 2001 W Orange Grove Rd Ste 612, Tucson, AZ 85704-1141 Ph: (520) 535-2004 | Dr Christopher L Marsh, DO 2001 W Orange Grove Rd Ste 612, Tucson, AZ 85704-1141 Ph: (520) 535-2004 |
News Archive
Particle Sciences and Microfluidics extended their collaboration with the placement of the newly-announced Microfluidics Reaction Technology system at Particle Sciences.
Perrigo Company today announced results for its first quarter ended September 26, 2009.
The first study to examine the actual willingness of older adults to be screened for dementia has found that acceptance of screening is pervasive, although it varies by age. However, willingness to be screened for dementia does not differ by sex, race or income level.
Mylan N.V. today announced the U.S. launch of Fluvastatin Sodium Extended-release Tablets, 80 mg, which is the generic version of Novartis' Lescol XL Tablets.
› Verified 8 days ago
Dr. Jeffrey T. Mack, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4001 E Sunrise Dr Ste 161, Tucson, AZ 85718 Phone: 520-408-6955 | |
Melissa Laura Ray, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2155 W Orange Grove Rd, Tucson, AZ 85741 Phone: 520-742-0414 Fax: 520-742-4063 | |
David L Massanari, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3945 E Paradise Falls Drive, Ste 201, Tucson, AZ 85712 Phone: 520-615-6200 Fax: 520-615-6255 | |
Violet P Siwik, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 707 N Alvernon Way Ste 101, Tucson, AZ 85711 Phone: 520-694-8888 Fax: 520-694-1640 | |
Dr. Ivy L Schwartz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2502 N Dodge Blvd, Suite 100, Tucson, AZ 85716 Phone: 520-618-8747 Fax: 520-882-5676 | |
Rhema Sayers, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 N Wilmot Rd, Suite 110, Tucson, AZ 85712 Phone: 520-884-4999 Fax: 520-300-6669 | |
Dr. Shauna Lee Mcisaac, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3550 N First Ave, Suite 300, Tucson, AZ 85719 Phone: 520-887-0715 Fax: 520-887-1315 |